small molecule

CETAPRED

PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM

Loss of exclusivity—loss of exclusivity

CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand name	CETAPRED
Active ingredient	PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
Strength	0.25%;10%
Dosage form	OINTMENT
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	August 1993
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.